Literature DB >> 16176937

Molecular motors implicated in the axonal transport of tau and alpha-synuclein.

Michelle A Utton1, Wendy J Noble, Josephine E Hill, Brian H Anderton, Diane P Hanger.   

Abstract

Tau and alpha-synuclein are both proteins implicated in the pathology of neurodegenerative disease. Here we have investigated the mechanisms of axonal transport of tau and alpha-synuclein, because failure of axonal transport has been implicated in the development of several neurodegenerative disorders. We found that the transport of both of these proteins depend on an intact microtubule- but not actin-cytoskeleton, and that tau and alpha-synuclein both move at overall slow rates of transport. We used time-lapse video microscopy to obtain images of live neurons that had been transfected with plasmids expressing proteins tagged with enhanced green fluorescent protein. We found that particulate structures containing tau or alpha-synuclein travel rapidly when moving along axons but spend the majority of the time paused, and these structures have similar characteristics to those previously observed for neurofilaments. The motile particles containing tau or alpha-synuclein colocalise with the fast-transporting molecular motor kinesin-1 in neurons. Co-immunoprecipitation experiments demonstrate that tau and alpha-synuclein are each associated with complexes containing kinesin-1, whereas only alpha-synuclein appears to interact with dynein-containing complexes. In vitro glutathione S-transferase-binding assays using rat brain homogenate or recombinant protein as bait reveals a direct interaction of kinesin-1 light chains 1 and 2 with tau, but not with alpha-synuclein. Our findings suggest that the axonal transport of tau occurs via a mechanism utilising fast transport motors, including the kinesin family of proteins, and that alpha-synuclein transport in neurons may involve both kinesin and dynein motor proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176937     DOI: 10.1242/jcs.02558

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  55 in total

1.  Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.

Authors:  Yaping Chu; Gerardo A Morfini; Lori B Langhamer; Yinzhen He; Scott T Brady; Jeffrey H Kordower
Journal:  Brain       Date:  2012-06-19       Impact factor: 13.501

2.  Alpha-synuclein loss in spinal muscular atrophy.

Authors:  Gyula Acsadi; Xingli Li; Kelley J Murphy; Kathryn J Swoboda; Graham C Parker
Journal:  J Mol Neurosci       Date:  2010-07-17       Impact factor: 3.444

3.  Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.

Authors:  Natalie Vavlitou; Irene Sargiannidou; Kyriaki Markoullis; Kyriacos Kyriacou; Steven S Scherer; Kleopas A Kleopa
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

Review 4.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

Review 5.  Review: regulation mechanisms of Kinesin-1.

Authors:  Sarah Adio; Jolante Reth; Friederike Bathe; Günther Woehlke
Journal:  J Muscle Res Cell Motil       Date:  2006-02-01       Impact factor: 2.698

6.  Role of MAP1B in axonal retrograde transport of mitochondria.

Authors:  Eva-María Jiménez-Mateos; Christian González-Billault; Hana N Dawson; Michael P Vitek; Jesús Avila
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

7.  Tau protein diffuses along the microtubule lattice.

Authors:  Maike H Hinrichs; Avesta Jalal; Bernhard Brenner; Eckhard Mandelkow; Satish Kumar; Tim Scholz
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

Review 8.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

9.  Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation.

Authors:  Aurora Bracale; Fabrizia Cesca; Veronika E Neubrand; Timothy P Newsome; Michael Way; Giampietro Schiavo
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

Review 10.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.